GABRIEL COIMBRA: Open Payments
NPI 1265197289 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 7 payments from 6 companies in 2025. Trend: 2023 $1,937 · 2024 $1,999 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 2 | $179 |
| Dexcom, Inc. | 1 | $150 |
| Outset Medical Inc | 1 | $125 |
| Novo Nordisk Inc | 1 | $116 |
| SANOFI PASTEUR INC. | 1 | $103 |
| Ardelyx, Inc. | 1 | $21 |
Products named: VELPHORO, DEXCOM G7 GSS (161), Ozempic, IBSRELA.
Industry payments across FL — which companies pay providers there.
